{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T02:52:59Z","timestamp":1775357579627,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.7759\/cureus.100582","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T21:23:07Z","timestamp":1767302587000},"source":"Crossref","is-referenced-by-count":1,"title":["Reality of Osteoporosis in Primary Healthcare: An Observational Study in a Portuguese Local Health Unit"],"prefix":"10.7759","author":[{"given":"Nuno","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia  S","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Martins Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Carlos","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao","family":"De Oliveira e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.03.009","article-title":"Postmenopausal osteoporosis: latest guidelines","volume":"50","author":"Arceo-Mendoza RM","year":"2021","unstructured":"Arceo-Mendoza RM, Camacho PM. Postmenopausal osteoporosis: latest guidelines. Endocrinol Metab Clin North Am. 2021, 50:167-78. 10.1016\/j.ecl.2021.03.009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000166","article-title":"Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey","volume":"2","author":"Branco JC","year":"2016","unstructured":"Branco JC, Rodrigues AM, Gouveia N, et al.. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey. RMD Open. 2016, 2:e000166. 10.1136\/rmdopen-2015-000166","journal-title":"RMD Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00969-8","article-title":"Osteoporosis in Europe: a compendium of country-specific reports","volume":"17","author":"Willers C","year":"2022","unstructured":"Willers C, Norton N, Harvey NC, et al.. Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos. 2022, 17:23. 10.1007\/s11657-021-00969-8","journal-title":"Arch Osteoporos"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis JA","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, et al.. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021, 16:82. 10.1007\/s11657-020-00871-9","journal-title":"Arch Osteoporos"},{"key":"ref5","article-title":"Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update","volume":"43","author":"Rodrigues AM","year":"2018","unstructured":"Rodrigues AM, Canh\u00e3o H, Marques A, et al.. Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 update. Acta Reumatol Port. 2018, 43:10-31.","journal-title":"Acta Reumatol Port"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston J","year":"2017","unstructured":"Compston J, Cooper A, Cooper C, et al.. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017, 12:43. 10.1007\/s11657-017-0324-5","journal-title":"Arch Osteoporos"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis JA","year":"2011","unstructured":"Kanis JA, Hans D, Cooper C, et al.. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011, 22:2395-411. 10.1007\/s00198-011-1713-z","journal-title":"Osteoporos Int"},{"key":"ref8","article-title":"Recommendations for the diagnosis and treatment of osteoporosis (Article in Portuguese)","volume":"32","author":"Portuguese Society of Rheumatology and Portuguese Society of Metabolic Bone Diseases","year":"2007","unstructured":"Portuguese Society of Rheumatology and Portuguese Society of Metabolic Bone Diseases. Recommendations for the diagnosis and treatment of osteoporosis (Article in Portuguese). Acta Reumatol Port. 2007, 32:49-59.","journal-title":"Acta Reumatol Port"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000001181","article-title":"Diagnosis and management of osteoporosis: a comprehensive review of guidelines","volume":"78","author":"Rentzeperi E","year":"2023","unstructured":"Rentzeperi E, Pegiou S, Tsakiridis I, et al.. Diagnosis and management of osteoporosis: a comprehensive review of guidelines. Obstet Gynecol Surv. 2023, 78:657-81. 10.1097\/OGX.0000000000001181","journal-title":"Obstet Gynecol Surv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston JE","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019, 393:364-76. 10.1016\/S0140-6736(18)32112-3","journal-title":"Lancet"},{"key":"ref11","unstructured":"Pharmacological treatment of postmenopausal osteoporosis. (2011). Accessed. 2025: https:\/\/normas.dgs.min-saude.pt\/2011\/09\/29\/tratamento-farmacologico-da-osteoporose-pos-menopausica\/."},{"key":"ref12","unstructured":"National network of hospital specialty and rheumatology referral. (2015). Accessed. 2025: https:\/\/www.sns.gov.pt\/wp-content\/uploads\/2016\/05\/rede-referencia%C3%A7%C3%A3o-hospitalar-reumatologia.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.29315\/gm.v9i2.584","article-title":"Osteoporosis in family medicine: are we doing what\u2019s necessary?","volume":"9","author":"Teixeira F","year":"2022","unstructured":"Teixeira F, Serejo R, Ara\u00fajo F. Osteoporosis in family medicine: are we doing what\u2019s necessary?. Gaz Med Port. 2022, 9:153-9. 10.29315\/gm.v9i2.584","journal-title":"Gaz Med Port"},{"key":"ref14","article-title":"A FRAX model for the estimation of osteoporotic fracture probability in Portugal","volume":"38","author":"Marques A","year":"2013","unstructured":"Marques A, Mota A, Canh\u00e3o H, et al.. A FRAX model for the estimation of osteoporotic fracture probability in Portugal. Acta Reumatol Port. 2013, 38:104-12.","journal-title":"Acta Reumatol Port"},{"key":"ref15","article-title":"World Health Organization. Assessment of Osteoporosis at the Primary Health Care Level. Geneva: WHO","author":"World Health Organization","year":"2007","unstructured":"World Health Organization. Assessment of Osteoporosis at the Primary Health Care Level. World Health Organization, Geneva, Switzerland; 2007. https:\/\/www.fraxplus.org\/sites\/frax\/files\/pdf\/WHO_Technical_Report.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff MS","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022, 33:2049-102. 10.1007\/s00198-021-05900-y","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.32385\/rpmgf.v32i6.11964","article-title":"Portuguese recommendations for ordering bone densitometry measurement and indications for treatment to prevent osteoporotic fractures (Article in Portuguese)","volume":"32","author":"Sociedade Portuguesa de Reumatologia","year":"2016","unstructured":"Sociedade Portuguesa de Reumatologia. Portuguese recommendations for ordering bone densitometry measurement and indications for treatment to prevent osteoporotic fractures (Article in Portuguese). Rev Port Med Geral Fam. 2016, 32:425-41. 10.32385\/rpmgf.v32i6.11964","journal-title":"Rev Port Med Geral Fam"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldaa005","article-title":"The epidemiology of osteoporosis","volume":"133","author":"Clynes MA","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020, 133:105-17. 10.1093\/bmb\/ldaa005","journal-title":"Br Med Bull"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund E","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M, et al.. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013, 8:136. 10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42115","article-title":"Impact of medication adherence on bone mineral density and fracture risk in patients with osteoporosis: a systematic review","volume":"15","author":"Alahmari MM","year":"2023","unstructured":"Alahmari MM, AlHilali AI, Thabet TA, et al.. Impact of medication adherence on bone mineral density and fracture risk in patients with osteoporosis: a systematic review. Cureus. 2023, 15:e42115. 10.7759\/cureus.42115","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1134-4","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis","volume":"21","author":"Imaz I","year":"2010","unstructured":"Imaz I, Zegarra P, Gonz\u00e1lez-Enr\u00edquez J, Rubio B, Alcazar R, Amate JM. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. 2010, 21:1943-51. 10.1007\/s00198-009-1134-4","journal-title":"Osteoporos Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris ES","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006, 81:1013-22. 10.4065\/81.8.1013","journal-title":"Mayo Clin Proc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman F","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014, 25:2359-81. 10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068033","article-title":"Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials","volume":"381","author":"H\u00e4ndel MN","year":"2023","unstructured":"H\u00e4ndel MN, Cardoso I, von B\u00fclow C, et al.. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ. 2023, 381:e068033. 10.1136\/bmj-2021-068033","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090506","article-title":"Risks and benefits of long-term bisphosphonate therapy","volume":"67","author":"Schmidt GA","year":"2010","unstructured":"Schmidt GA, Horner KE, McDanel DL, Ross MB, Moores KG. Risks and benefits of long-term bisphosphonate therapy. Am J Health Syst Pharm. 2010, 67:994-1001. 10.2146\/ajhp090506","journal-title":"Am J Health Syst Pharm"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724010-00003","article-title":"Patient adherence to osteoporosis medications: problems, consequences and management strategies","volume":"24","author":"Papaioannou A","year":"2007","unstructured":"Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging. 2007, 24:37-55. 10.2165\/00002512-200724010-00003","journal-title":"Drugs Aging"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0073-6","article-title":"Determinants of adherence to osteoporosis treatment in clinical practice","volume":"17","author":"Rossini M","year":"2006","unstructured":"Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int. 2006, 17:914-21. 10.1007\/s00198-006-0073-6","journal-title":"Osteoporos Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441068-reality-of-osteoporosis-in-primary-healthcare-an-observational-study-in-a-portuguese-local-health-unit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T21:23:09Z","timestamp":1767302589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441068-reality-of-osteoporosis-in-primary-healthcare-an-observational-study-in-a-portuguese-local-health-unit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.100582","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}